Table V.
Univariate analysis | Multivariate analysis | |||||
---|---|---|---|---|---|---|
Variables | HR | P-value | 95% CI | HR | P-value | 95% CI |
Expression of MAGE-As, high vs. low | 2.048 | 0.024a | 1.099-3.816 | |||
Expression of MAGE-A1, high vs. low | 1.948 | 0.068 | 0.951-3.990 | |||
Expression of MAGE-A2, high vs. low | 2.297 | 0.014a | 1.187-4.443 | 2.137 | 0.050 | 1.001-4.561 |
Expression of MAGE-A3, high vs. low | 2.016 | 0.041a | 1.028-3.954 | 1.207 | 0.731 | 0.412-3.540 |
Expression of MAGE-A4, high vs. low | 2.131 | 0.046a | 1.013-4.482 | 2.339 | 0.174 | 0.686-7.970 |
Expression of MAGE-A6, high vs. low | 4.050 | <0.001a | 1.958-8.376 | 1.410 | 0.480 | 0.543-3.665 |
Expression of MAGE-A9, high vs. low | 3.204 | <0.001a | 1.722-5.961 | 2.082 | 0.065 | 0.954-4.543 |
Expression of MAGE-A11, high vs. low | 3.019 | <0.001a | 1.636-5.573 | 2.438 | 0.032a | 1.080-5.504 |
Age, years, <60 vs. ≥60 | 1.369 | 0.327 | 0.730-2.566 | |||
Tumor location, supraglottic vs. glottic | 1.839 | 0.053 | 0.992-3.409 | |||
Smoking index, <400 vs. ≥400 | 1.335 | 0.381 | 0.700-2.547 | |||
Tumor size, cm, <2 vs. ≥2 | 1.924 | 0.057 | 0.981-3.777 | |||
Histological grade, G1/G2 vs. G3 | 2.013 | 0.028a | 1.078-3.760 | 1.290 | 0.544 | 0.568-2.931 |
Clinical stage (AJCC), I/II vs. III/IV | 2.345 | 0.013a | 1.194-4.604 | |||
Metastatic state of lymph node, N vs. N0 | 10.788 | <0.001a | 5.036-23.110 | 21.112 | <0.001a | 7.927-56.226 |
P<0.05. MAGE, melanoma-associated antigen; HR, hazard ratio; CI, confidence interval; N, patients with lymph node metastasis; AJCC, American Joint Committee on Cancer.